Dr. Arindam Banerjee
Achiever's Success Story
Giving Scientific Perspective Towards a New Hope, under Dr. Arindam Banerjee’s leadership, LifeSenz aims to provide cancer therapy at the personal front
LifeSenz Ltd is a biomedical company that aims on improving patients’ lives by providing guidance for precision cancer therapy at the personal front. Under the leadership of Dr. Arindam Banerjee, they are also, building a bridge between academia and industry in the bio-pharma sector by providing quality R&D based training to relevant biopharmaceutical professionals or students and collaborating with industry/ academic partners to contribute in research and innovation-based subjects; direct impacting on improving cancer patient’s lives.
Dr. Arindam Banerjee, the CEO and director of LifeSenz Ltd, holds a PhD in Molecular Medicine from The University of Auckland, New Zealand and subsequent relevant work experience across various international locations such as UK, Singapore, New Zealand and India. Dr Banerjee has contributed to multiple peer reviewed scientific publications and got accolades at various international scientific meetings. Dr Banerjee is also an expert in advanced in vitro and ex vivo cell modelling-based platform development in cancer therapeutics field.
Mr. Banerjee says that Standard chemotherapy treatment approach of ‘one size fits all’ may not always provide the anticipatory therapy response. Hence, predictive and precise selection of an appropriate drug/s at the individual level before treatment begins, could provide better therapy outcomes within relatively less timeframe. This could save both TIME & MONEY and thereby beneficial to the patient.
He also adds that In house, quality R&D work on translational cancer research at per international levels could be helpful to develop new avenues of an affordable cancer therapy which may be beneficial to the patient’s lives. Moreover, lack of competent scientific talent pool of international standards is another concern to build a high standard scientific ecosystem in our country. In summary, LifeSenz’s activities could address the skill gap, precising and improving the therapy outcomes in patient and contributes in developing a knowledge based scientific ecosystem that has value both in local as well as global perspectives.